These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 8397270

  • 1. Release of soluble receptors for tumor necrosis factor in clinical sepsis and experimental endotoxemia.
    van der Poll T, Jansen J, van Leenen D, von der Möhlen M, Levi M, ten Cate H, Gallati H, ten Cate JW, van Deventer SJ.
    J Infect Dis; 1993 Oct; 168(4):955-60. PubMed ID: 8397270
    [Abstract] [Full Text] [Related]

  • 2. Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia.
    Spinas GA, Keller U, Brockhaus M.
    J Clin Invest; 1992 Aug; 90(2):533-6. PubMed ID: 1322942
    [Abstract] [Full Text] [Related]

  • 3. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity.
    Steinshamn S, Bemelmans MH, Buurman WA, Waage A.
    Cytokine; 1995 Jan; 7(1):50-6. PubMed ID: 7749066
    [Abstract] [Full Text] [Related]

  • 4. Increased release of soluble tumor necrosis factor receptors into blood during clinical sepsis.
    Ertel W, Scholl FA, Gallati H, Bonaccio M, Schildberg FW, Trentz O.
    Arch Surg; 1994 Dec; 129(12):1330-6; discussion 1336-7. PubMed ID: 7986165
    [Abstract] [Full Text] [Related]

  • 5. Release of bactericidal/permeability-increasing protein in experimental endotoxemia and clinical sepsis. Role of tumor necrosis factor.
    von der Möhlen MA, van der Poll T, Jansen J, Levi M, van Deventer SJ.
    J Immunol; 1996 Jun 15; 156(12):4969-73. PubMed ID: 8648149
    [Abstract] [Full Text] [Related]

  • 6. Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
    Landmann R, Keilholz U, Scheibenbogen C, Brockhaus M, Gallati H, Denz H, Bargetzi M, Ludwig C.
    Cancer Immunol Immunother; 1994 Feb 15; 38(2):113-8. PubMed ID: 8306366
    [Abstract] [Full Text] [Related]

  • 7. Serum levels of p55 and p75 soluble TNF receptors in adult acute leukaemia at diagnosis: correlation with clinical and biological features and outcome.
    Vinante F, Rigo A, Tecchio C, Morosato L, Nadali G, Ricetti MM, Krampera M, Zanolin E, Locatelli F, Gallati H, Chilosi M, Pizzolo G.
    Br J Haematol; 1998 Sep 15; 102(4):1025-34. PubMed ID: 9734654
    [Abstract] [Full Text] [Related]

  • 8. Pentoxifylline attenuates neutrophil activation in experimental endotoxemia in chimpanzees.
    van Leenen D, van der Poll T, Levi M, ten Cate H, van Deventer SJ, Hack CE, Aarden LA, ten Cate JW.
    J Immunol; 1993 Aug 15; 151(4):2318-25. PubMed ID: 8345209
    [Abstract] [Full Text] [Related]

  • 9. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B, van der Poll T, Levi M, van Deventer SJ, ten Cate H, Imai Y, Hack CE, ten Cate JW.
    J Immunol; 1994 Mar 01; 152(5):2438-46. PubMed ID: 8133055
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD.
    J Clin Invest; 1994 Jan 01; 93(1):114-20. PubMed ID: 8282778
    [Abstract] [Full Text] [Related]

  • 11. Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis.
    Evans TJ, Moyes D, Carpenter A, Martin R, Loetscher H, Lesslauer W, Cohen J.
    J Exp Med; 1994 Dec 01; 180(6):2173-9. PubMed ID: 7964492
    [Abstract] [Full Text] [Related]

  • 12. Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection.
    Itoh Y, Okanoue T, Ohnishi N, Sakamoto M, Nishioji K, Nakagawa Y, Minami M, Murakami Y, Kashima K.
    Am J Gastroenterol; 1999 May 01; 94(5):1332-40. PubMed ID: 10235215
    [Abstract] [Full Text] [Related]

  • 13. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
    Robak T, Gladalska A, Stepień H.
    Eur Cytokine Netw; 1998 Jun 01; 9(2):145-54. PubMed ID: 9681390
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. LPS-induced sTNF-receptor release in vivo in a murine model. Investigation of the role of tumor necrosis factor, IL-1, leukemia inhibiting factor, and IFN-gamma.
    Bemelmans MH, Gouma DJ, Buurman WA.
    J Immunol; 1993 Nov 15; 151(10):5554-62. PubMed ID: 8228246
    [Abstract] [Full Text] [Related]

  • 17. Soluble tumour necrosis factor receptors, tumour necrosis factor and interleukin-6 in serum in granulocytopenic patients with fever.
    Steinshamn S, Brekke OL, Waage A.
    Br J Haematol; 1995 Apr 15; 89(4):719-24. PubMed ID: 7772508
    [Abstract] [Full Text] [Related]

  • 18. Production of soluble tumor necrosis factor receptors and tumor necrosis factor-alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis.
    Dai H, Guzman J, Chen B, Costabel U.
    Chest; 2005 Jan 15; 127(1):251-6. PubMed ID: 15653992
    [Abstract] [Full Text] [Related]

  • 19. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus.
    Aderka D, Wysenbeek A, Engelmann H, Cope AP, Brennan F, Molad Y, Hornik V, Levo Y, Maini RN, Feldmann M.
    Arthritis Rheum; 1993 Aug 15; 36(8):1111-20. PubMed ID: 8393677
    [Abstract] [Full Text] [Related]

  • 20. Effect of 1 alpha-hydroxyvitamin D3 treatment on production of tumor necrosis factor-alpha by peripheral blood mononuclear cells and on serum concentrations of soluble tumor necrosis factor receptors in hemodialysis patients.
    Haran N, Gurwicz S, Gallati H, Shalita B, Bar-Khayim Y.
    Nephron; 1994 Aug 15; 66(3):262-6. PubMed ID: 8190177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.